The Discounted Cash Flow (DCF) valuation of Flexion Therapeutics Inc (FLXN) is (276.06) USD. With the latest stock price at 9.12 USD, the upside of Flexion Therapeutics Inc based on DCF is -3127.0%.
Based on the latest price of 9.12 USD and our DCF valuation, Flexion Therapeutics Inc (FLXN) is a sell. selling FLXN stocks now will result in a potential gain of 3127.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.7% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,150.67) - (161.76) | (276.06) |
| Upside | -12717.0% - -1873.6% | -3127.0% |